Association of mediastinal lymphadenopathy with COVID-19 prognosis
Item
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Item Type
PublicationTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Title
Association of mediastinal lymphadenopathy with COVID-19 prognosis
Subject
Description
Xavier Valette and colleagues reported a high (66%) prevalence of mediastinal lymphadenopathy in 15 patients with COVID-19 admitted to their intensive care unit (ICU), an approximately 11-fold discrepancy with systematic reviews reporting pooled prevalence of 3·4% and 5·4%.
Date
2020-06-19
Type
Citation
Sardanelli, Francesco, Andrea Cozzi, Lorenzo Monfardini, Claudio Bnà, Riccardo Alessandro Foà, Angelo Spinazzola, Silvia Tresoldi, Maurizio Cariati, Francesco Secchi, and Simone Schiaffino. 2020. "Association of mediastinal lymphadenopathy with COVID-19 prognosis." The Lancet Infectious Diseases.
Accessibility
Free online on Lancet site.
Was this resource helpful?